FILE PHOTO: German Chancellor Angela Merkel checks a magnetic resonance imaging machine as she visits Siemens Healthineers in Shenzhen, China May 25, 2018. REUTERS/Bobby Yip/File Photo
BERLIN (Reuters) - European and U.S. pharmaceutical associations have waded into a diplomatic row between Germany and Saudi Arabia, warning that ongoing restrictions on German-made drugs could hurt Saudi patients and dampen future investment in the kingdom.
In a strongly worded letter to Crown Prince Mohammed bin Salman, a copy of which has been seen by Reuters, the associations highlighted the level of concern in Germany and elsewhere about restrictive procurement measures implemented by Riyadh in response to criticism of its policies.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
